Hexaminolevulinate Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06261 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | bronchitis | KG + DL |
| 2 | colonic neoplasm | KG + DL |
| 3 | severe nonproliferative diabetic retinopathy | KG + DL |
| 4 | cecum villous adenoma | KG + DL |
| 5 | rectosigmoid junction neoplasm | KG + DL |
| 6 | cecum neuroendocrine tumor G1 | KG + DL |
| 7 | colonic lymphangioma | KG + DL |
| 8 | lipoma of colon | KG + DL |
| 9 | cecal disease | KG + DL |
| 10 | cavernous hemangioma of colon | KG + DL |
| 11 | benign neoplasm of cecum | KG + DL |
| 12 | colon leiomyoma | KG + DL |
| 13 | diabetic retinopathy | KG + DL |
| 14 | plasma cell myeloma | KG + DL |
| 15 | urinary bladder neoplasm | KG + DL |
| 16 | bladder squamous papilloma | KG + DL |
| 17 | urinary bladder carcinoma | KG + DL |
| 18 | drug-induced osteoporosis | KG + DL |
| 19 | bladder urothelial papilloma | KG + DL |
| 20 | indolent plasma cell myeloma | KG + DL |
| 21 | bronchial neoplasm (disease) | KG + DL |
| 22 | gastric carcinoma | KG + DL |
| 23 | bladder leiomyoma | KG + DL |
| 24 | infiltrating bladder urothelial carcinoma | KG + DL |
| 25 | diffuse gastric adenocarcinoma | KG + DL |
| 26 | non-invasive bladder urothelial carcinoma | KG + DL |
| 27 | bladder signet ring cell adenocarcinoma | KG + DL |
| 28 | bladder mixed adenocarcinoma | KG + DL |
| 29 | bladder colloid adenocarcinoma | KG + DL |
| 30 | bladder colonic type adenocarcinoma | KG + DL |
| 31 | bladder urachal urothelial carcinoma | KG + DL |
| 32 | bladder clear cell adenocarcinoma | KG + DL |
| 33 | gastric linitis plastica | KG + DL |
| 34 | bladder urachal adenocarcinoma | KG + DL |
| 35 | bladder dome cancer | KG + DL |
| 36 | urachus cancer | KG + DL |
| 37 | urinary bladder cancer | KG + DL |
| 38 | bladder neck cancer | KG + DL |
| 39 | malignant tumor of meninges | KG + DL |
| 40 | Epstein-Barr virus-associated carcinoma | KG + DL |
| 41 | diabetic cataract | KG + DL |
| 42 | spinal cord cancer | KG + DL |
| 43 | carcinoma in situ of gastric cardia | KG + DL |
| 44 | carcinoma in situ of gastric body | KG + DL |
| 45 | gastric cardia adenocarcinoma | KG + DL |
| 46 | urinary system neoplasm | KG + DL |
| 47 | gastric adenocarcinoma and proximal polyposis of the stomach | KG + DL |
| 48 | bladder sarcoma | KG + DL |
| 49 | urinary bladder anterior wall cancer | KG + DL |
| 50 | bladder lateral wall cancer | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.